Beranda › Penyakit Alzheimer › Nevada
Uji klinis Penyakit Alzheimer di Nevada
8 studi untuk Penyakit Alzheimer mencari peserta di lokasi di Nevada.
Kota di Nevada
Teks studi resmi (Bahasa Inggris)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Las Vegas
Menerima pesertaFase 2
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2628, Las Vegas
- Redbird Research, Las Vegas
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06937229A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Las Vegas Clinical Trials, Las Vegas
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Redbird Research, Las Vegas
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07011732A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Vector Clinical Trials, Las Vegas
Menerima pesertaFase 3
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Lou Ruvo Center for Brain Health, Las Vegas
Menerima pesertaFase 2
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT07094516Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Cleveland Clinic, Lou Ruvo Center for Brain Health, Las Vegas, Las Vegas
Menerima pesertaStudi observasional
Usia 25 hingga 55 · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT04165109Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Clinical Neurology Specialists, Las Vegas
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 60 hingga 90 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT06584357Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.